What is a stock summary page? Click here for an overview.
Business Description
Sinohealth Holdings Ltd
ISIN : KYG8192Q1064
Compare
Compare
Traded in other countries / regions
02361.Hong Kong IPO Date
2022-07-12Description
Sinohealth is a leading provider of Big Data and artificial intelligence-based marketing and distribution information tools, including SaaS-based customer relationship management solutions to mainland China medical product manufacturers. It sources retail data through pharmacy partnerships and provides data analysis to the pharmaceutical and corporate clients it serves. Since its establishment in 2007, its focus has been on building a strong Big Data engine and networking capabilities to assist clients in their product investments and sales and marketing strategies. It is now launching various cloud-based systems and platform solutions for its clients and expanding its SaaS products, which are expected to be the key growth driver in future.
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 36.03 | |||||
Equity-to-Asset | 0.84 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | 0.12 | |||||
Interest Coverage | 166.09 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 10.56 | |||||
Beneish M-Score | -1.91 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 24.1 | |||||
3-Year EBITDA Growth Rate | 11.2 | |||||
3-Year EPS without NRI Growth Rate | 26.4 | |||||
3-Year FCF Growth Rate | 6.9 | |||||
3-Year Book Growth Rate | 15 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 13.68 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 72 | |||||
9-Day RSI | 60.74 | |||||
14-Day RSI | 55.08 | |||||
3-1 Month Momentum % | -29.23 | |||||
6-1 Month Momentum % | -21.37 | |||||
12-1 Month Momentum % | -32.48 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 5.26 | |||||
Quick Ratio | 5.2 | |||||
Cash Ratio | 4.24 | |||||
Days Inventory | 7.99 | |||||
Days Sales Outstanding | 75.71 | |||||
Days Payable | 24.48 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 1.93 | |||||
Dividend Payout Ratio | 0.24 | |||||
Forward Dividend Yield % | 1.93 | |||||
5-Year Yield-on-Cost % | 2.22 | |||||
3-Year Average Share Buyback Ratio | 2.7 | |||||
Shareholder Yield % | 9.39 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 57.73 | |||||
Operating Margin % | 27.9 | |||||
Net Margin % | 23.32 | |||||
FCF Margin % | 11.92 | |||||
ROE % | 13.62 | |||||
ROA % | 11.67 | |||||
ROIC % | 40.18 | |||||
3-Year ROIIC % | 17.88 | |||||
ROC (Joel Greenblatt) % | 295.33 | |||||
ROCE % | 14.85 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 15 | |||||
Forward PE Ratio | 14.65 | |||||
PE Ratio without NRI | 12.3 | |||||
Price-to-Owner-Earnings | 18.48 | |||||
PS Ratio | 3.54 | |||||
PB Ratio | 2.08 | |||||
Price-to-Tangible-Book | 2.12 | |||||
Price-to-Free-Cash-Flow | 29.53 | |||||
Price-to-Operating-Cash-Flow | 28.41 | |||||
EV-to-EBIT | 7.02 | |||||
EV-to-Forward-EBIT | 10.9 | |||||
EV-to-EBITDA | 6.53 | |||||
EV-to-Forward-EBITDA | 10.38 | |||||
EV-to-Revenue | 1.81 | |||||
EV-to-Forward-Revenue | 2.71 | |||||
EV-to-FCF | 17.66 | |||||
Price-to-Graham-Number | 1.08 | |||||
Price-to-Net-Current-Asset-Value | 2.88 | |||||
Price-to-Net-Cash | 3.83 | |||||
Earnings Yield (Greenblatt) % | 14.25 | |||||
FCF Yield % | 3.47 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sinohealth Holdings Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil HK$) | 446.547 | ||
EPS (TTM) (HK$) | 0.25 | ||
Beta | - | ||
3-Year Sharpe Ratio | - | ||
3-Year Sortino Ratio | - | ||
Volatility % | 62.24 | ||
14-Day RSI | 55.08 | ||
14-Day ATR (HK$) | 0.239198 | ||
20-Day SMA (HK$) | 3.496 | ||
12-1 Month Momentum % | -32.48 | ||
52-Week Range (HK$) | 2.24 - 5.5 | ||
Shares Outstanding (Mil) | 409.08 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Sinohealth Holdings Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Sinohealth Holdings Ltd Stock Events
Event | Date | Price (HK$) | ||
---|---|---|---|---|
No Event Data |
Sinohealth Holdings Ltd Frequently Asked Questions
What is Sinohealth Holdings Ltd(HKSE:02361)'s stock price today?
The current price of HKSE:02361 is HK$3.75. The 52 week high of HKSE:02361 is HK$5.50 and 52 week low is HK$2.24.
When is next earnings date of Sinohealth Holdings Ltd(HKSE:02361)?
The next earnings date of Sinohealth Holdings Ltd(HKSE:02361) is 2025-08-28 Est..
Does Sinohealth Holdings Ltd(HKSE:02361) pay dividends? If so, how much?
The Dividend Yield %  of Sinohealth Holdings Ltd(HKSE:02361) is 1.93% (As of Today), Highest Dividend Payout Ratio of Sinohealth Holdings Ltd(HKSE:02361) was 0.24. The lowest was 0.13. And the median was 0.13. The  Forward Dividend Yield % of Sinohealth Holdings Ltd(HKSE:02361) is 1.93%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |